Kerstin Roback
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kerstin Roback has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Per Nilsen
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden
8 shared publications Per Carlsson
Linköping University, Linköping, Sweden
3 shared publicationsAlmina Kalkan
Linköping University, Linköping, Sweden
2 shared publications- Annica Ohrn
Department of Medical and Health Sciences, Linköping University, Sweden
2 shared publications Eva Hallert
Linköping University, Linköping, Sweden
2 shared publications- Mikael Rahmqvist
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
2 shared publications
Latest Publications
- Open Access
- 21 March 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 391
Beliefs and attitudes about addressing alcohol consumption in health care: a population survey in England
Despite robust evidence for their effectiveness, it has proven difficult to translate alcohol prevention activities into routine health care practice. Previous research has identified numerous provider-level barriers affecting implementation, but these have been less extensively investigated in the wider population. We sought to: (1) investigate patients’ beliefs and attitudes to being asked about alcohol consumption in health care; and (2) identify the characteristics of those who are supportive of addressing alcohol consumption in health care. Cross-sectional household interviews conducted as part of the national Alcohol Toolkit Study in England between March and April 2017. Data were collected on age, gender, social grade, drinking category, and beliefs and attitudes to being asked about alcohol in routine health care. Unadjusted and multivariate-adjusted logistic regression models were performed to investigate associations between socio-demographic characteristics and drinking category with being “pro-routine” (i.e. ‘agree completely’ that alcohol consumption should be routinely addressed in health care) or “pro-personal” (i.e. ‘agree completely’ that alcohol is a personal matter and not something health care providers should ask about). Data were collected on 3499 participants, of whom 50% were “pro-routine” and 10% were “pro-personal”. Those in social grade C1, C2, D and E were significantly less likely than those in AB of being “pro-routine”. Women were less likely than men to be “pro-personal”, and those aged 35–44 or 65 years plus more likely to be “pro-personal” compared with participants aged 16–24. Respondents aged 65 plus were twice as likely as those aged 16–24 to agree completely that alcohol consumption is a personal matter and not something health care providers should ask about (OR 2.00, 95% CI 1.34–2.99). Most adults in England agree that health care providers should routinely ask about patients’ alcohol consumption. However, older adults and those in lower socio-economic groups are less supportive. Drinking status appears to have limited impact on whether people believe that alcohol is a personal matter and not something health care providers should ask about. Open Science Framework ( https://osf.io/xn2st/ ).
- 21 March 2018
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 391
Open AccessBeliefs and attitudes about addressing alcohol consumption in health care: a population survey in England
Despite robust evidence for their effectiveness, it has proven difficult to translate alcohol prevention activities into routine health care practice. Previous research has identified numerous provider-level barriers affecting implementation, but these have been less extensively investigated in the wider population. We sought to: (1) investigate patients’ beliefs and attitudes to being asked about alcohol consumption in health care; and (2) identify the characteristics of those who are supportive of addressing alcohol consumption in health care. Cross-sectional household interviews conducted as part of the national Alcohol Toolkit Study in England between March and April 2017. Data were collected on age, gender, social grade, drinking category, and beliefs and attitudes to being asked about alcohol in routine health care. Unadjusted and multivariate-adjusted logistic regression models were performed to investigate associations between socio-demographic characteristics and drinking category with being “pro-routine” (i.e. ‘agree completely’ that alcohol consumption should be routinely addressed in health care) or “pro-personal” (i.e. ‘agree completely’ that alcohol is a personal matter and not something health care providers should ask about). Data were collected on 3499 participants, of whom 50% were “pro-routine” and 10% were “pro-personal”. Those in social grade C1, C2, D and E were significantly less likely than those in AB of being “pro-routine”. Women were less likely than men to be “pro-personal”, and those aged 35–44 or 65 years plus more likely to be “pro-personal” compared with participants aged 16–24. Respondents aged 65 plus were twice as likely as those aged 16–24 to agree completely that alcohol consumption is a personal matter and not something health care providers should ask about (OR 2.00, 95% CI 1.34–2.99). Most adults in England agree that health care providers should routinely ask about patients’ alcohol consumption. However, older adults and those in lower socio-economic groups are less supportive. Drinking status appears to have limited impact on whether people believe that alcohol is a personal matter and not something health care providers should ask about. Open Science Framework ( https://osf.io/xn2st/ ).
- Open Access
- 2 August 2017
- Published by Springer Nature in Implementation Science
- Vol. 12 (1) , 1-8
Five years’ experience of an annual course on implementation science: an evaluation among course participants
Increasing interest in implementation science has generated a demand for education and training opportunities for researchers and practitioners in the field. However, few implementation science courses have been described or evaluated in the scientific literature. The aim of the present study was to provide a short- and long-term evaluation of the implementation training at Linköping University, Sweden. Two data collections were carried out. In connection with the final seminar, a course evaluation form, including six items on satisfaction and suggestions for improvement, was distributed to the course participants, a total of 101 students from 2011 to 2015 (data collection 1), response rate 72%. A questionnaire including six items was distributed by e-mail to the same students in autumn 2016 (data collection 2), response rate 63%. Data from the two data collections were presented descriptively and analysed using the Kirkpatrick model consisting of four levels: reaction, learning, behaviour and results. The students were very positive immediately after course participation, rating high on overall perception of the course and the contents (reaction). The students also rated high on achievement of the course objectives and considered their knowledge in implementation science to be very good and to a high degree due to course participation (learning). Knowledge gained from the course was viewed to be useful (behaviour) and was applied to a considerable extent in research projects and work apart from research activities (results). The evaluation of the doctoral-level implementation science course provided by Linköping University showed favourable results, both in the short and long term. The adapted version of the Kirkpatrick model was useful because it provided a structure for evaluation of the short- and long-term learning outcomes.
- 2 August 2017
- Published by Springer Nature in Implementation Science
- Vol. 12 (1) , 1-8
Open AccessFive years’ experience of an annual course on implementation science: an evaluation among course participants
Increasing interest in implementation science has generated a demand for education and training opportunities for researchers and practitioners in the field. However, few implementation science courses have been described or evaluated in the scientific literature. The aim of the present study was to provide a short- and long-term evaluation of the implementation training at Linköping University, Sweden. Two data collections were carried out. In connection with the final seminar, a course evaluation form, including six items on satisfaction and suggestions for improvement, was distributed to the course participants, a total of 101 students from 2011 to 2015 (data collection 1), response rate 72%. A questionnaire including six items was distributed by e-mail to the same students in autumn 2016 (data collection 2), response rate 63%. Data from the two data collections were presented descriptively and analysed using the Kirkpatrick model consisting of four levels: reaction, learning, behaviour and results. The students were very positive immediately after course participation, rating high on overall perception of the course and the contents (reaction). The students also rated high on achievement of the course objectives and considered their knowledge in implementation science to be very good and to a high degree due to course participation (learning). Knowledge gained from the course was viewed to be useful (behaviour) and was applied to a considerable extent in research projects and work apart from research activities (results). The evaluation of the doctoral-level implementation science course provided by Linköping University showed favourable results, both in the short and long term. The adapted version of the Kirkpatrick model was useful because it provided a structure for evaluation of the short- and long-term learning outcomes.
- Open Access
- 21 March 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 1-9
Patient safety work in Sweden: quantitative and qualitative analysis of annual patient safety reports
There is widespread recognition of the problem of unsafe care and extensive efforts have been made over the last 15 years to improve patient safety. In Sweden, a new patient safety law obliges the 21 county councils to assemble a yearly patient safety report (PSR). The aim of this study was to describe the patient safety work carried out in Sweden by analysing the PSRs with regard to the structure, process and result elements reported, and to investigate the perceived usefulness of the PSRs as a tool to achieve improved patient safety. The study was based on two sources of data: patient safety reports obtained from county councils in Sweden published in 2014 and a survey of health care practitioners with strategic positions in patient safety work, acting as key informants for their county councils. Answers to open-ended questions were analysed using conventional content analysis. A total of 14 structure elements, 31 process elements and 23 outcome elements were identified. The most frequently reported structure elements were groups devoted to working with antibiotics issues and electronic incident reporting systems. The PSRs were perceived to provide a structure for patient safety work, enhance the focus on patient safety and contribute to learning about patient safety. Patient safety work carried out in Sweden, as described in annual PSRs, features a wide range of structure, process and result elements. According to health care practitioners with strategic positions in the county councils’ patient safety work, the PSRs are perceived as useful at various system levels.
- 21 March 2016
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 1-9
Open AccessPatient safety work in Sweden: quantitative and qualitative analysis of annual patient safety reports
There is widespread recognition of the problem of unsafe care and extensive efforts have been made over the last 15 years to improve patient safety. In Sweden, a new patient safety law obliges the 21 county councils to assemble a yearly patient safety report (PSR). The aim of this study was to describe the patient safety work carried out in Sweden by analysing the PSRs with regard to the structure, process and result elements reported, and to investigate the perceived usefulness of the PSRs as a tool to achieve improved patient safety. The study was based on two sources of data: patient safety reports obtained from county councils in Sweden published in 2014 and a survey of health care practitioners with strategic positions in patient safety work, acting as key informants for their county councils. Answers to open-ended questions were analysed using conventional content analysis. A total of 14 structure elements, 31 process elements and 23 outcome elements were identified. The most frequently reported structure elements were groups devoted to working with antibiotics issues and electronic incident reporting systems. The PSRs were perceived to provide a structure for patient safety work, enhance the focus on patient safety and contribute to learning about patient safety. Patient safety work carried out in Sweden, as described in annual PSRs, features a wide range of structure, process and result elements. According to health care practitioners with strategic positions in the county councils’ patient safety work, the PSRs are perceived as useful at various system levels.
- 24 November 2015
- Published by Wiley in Arthritis Care & Research
- Vol. 67 (12) , 1679-1685
Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register‐Based Study of 4,010 Patients in Sweden
Objective The prescription of biological drugs for rheumatoid arthritis (RA) patients has varied considerably across different regions. Previous studies have shown physician preferences to be an important determinant in the decision to select biological disease‐modifying anti‐rheumatic drugs (bDMARDs) rather than non‐biologic, synthetic DMARDs (sDMARDs) alone. The aim of this study was to test the hypothesis that physician preferences are an important determinant for prescribing bDMARDs for RA patients in Sweden. Methods Using data from the Swedish Rheumatology Quality Register, we identified 4010 RA patients who were not prescribed bDMARDs during the period 2008‐2012, but who, on at least one occasion, had an sDMARD prescription and changed treatment for the first time to either a new sDMARD or a bDMARD. Physician preference for the use of bDMARDs was calculated using data on each physician's prescriptions during the study period. The relationship between prescription of a bDMARD and physician preference, controlling for patient characteristics, disease activity and the physician's local context was evaluated using multivariate logistic regression. Results When adjusting for patient characteristics, disease activity and the physician's local context, physician preference was an important predictor for prescription of bDMARDs. Compared with patients of a physician in the lowest preference tertile, patients of physicians in the highest and middle tertiles had an odds ratio for receiving bDMARD of 2.8 (95% CI 2.13‐3.68) and 1.28 (95% CI 1.05‐1.57), respectively. Conclusion Physician preference is an important determinant for prescribing bDMARDs.
- 24 November 2015
- Published by Wiley in Arthritis Care & Research
- Vol. 67 (12) , 1679-1685
Physician Preferences and Variations in Prescription of Biologic Drugs for Rheumatoid Arthritis: A Register‐Based Study of 4,010 Patients in Sweden
Objective The prescription of biological drugs for rheumatoid arthritis (RA) patients has varied considerably across different regions. Previous studies have shown physician preferences to be an important determinant in the decision to select biological disease‐modifying anti‐rheumatic drugs (bDMARDs) rather than non‐biologic, synthetic DMARDs (sDMARDs) alone. The aim of this study was to test the hypothesis that physician preferences are an important determinant for prescribing bDMARDs for RA patients in Sweden. Methods Using data from the Swedish Rheumatology Quality Register, we identified 4010 RA patients who were not prescribed bDMARDs during the period 2008‐2012, but who, on at least one occasion, had an sDMARD prescription and changed treatment for the first time to either a new sDMARD or a bDMARD. Physician preference for the use of bDMARDs was calculated using data on each physician's prescriptions during the study period. The relationship between prescription of a bDMARD and physician preference, controlling for patient characteristics, disease activity and the physician's local context was evaluated using multivariate logistic regression. Results When adjusting for patient characteristics, disease activity and the physician's local context, physician preference was an important predictor for prescription of bDMARDs. Compared with patients of a physician in the lowest preference tertile, patients of physicians in the highest and middle tertiles had an odds ratio for receiving bDMARD of 2.8 (95% CI 2.13‐3.68) and 1.28 (95% CI 1.05‐1.57), respectively. Conclusion Physician preference is an important determinant for prescribing bDMARDs.
- 1 January 2015
- Published by Medknow
- Vol. 44 (4) , 265-70
Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis
Objective: In Sweden, reports indicate surprisingly large regional variation in prescription of biological drugs, despite a growing number of clinical studies describing their beneficial effects and guidelines by professional organizations and agencies. Our objective was to ascertain whether there is also variation between individual rheumatologists in prescribing biologics to patients with rheumatoid arthritis (RA) and to evaluate reasons for treatment choices. Methods: Ten hypothetical patient cases were constructed and presented to 26 rheumatologists in five regions in Sweden. The cases were based on actual cases and were thoroughly elaborated by a senior rheumatologist and pre-tested in a pilot study. The respondents were asked whether they would treat the patients with a biological agent (YES/NO) and to explain their decisions. Results: The response rate was 26/105; 25%. Treatment choices varied considerably between the rheumatologists, some prescribing biologics to 9/10 patients and others to 2/10. In five of the ten hypothetical cases, approximately half of the respondents would prescribe biologics. No regions with particularly high or low prescription were identified. Both the decision to prescribe biologics, as well as not to prescribe, were mainly motivated by medical reasons. Some rheumatologists also referred to lifestyle-related factors or social function of the patient. Conclusion: The choice of initiation of biologics varied substantially among rheumatologists presented with hypothetical patient cases, and there were also disparities between rheumatologists practising at the same clinic. Treatment choices were primarily motivated by medical reasons. This situation raises concerns about a lack of consensus in RA treatment strategies
- 1 January 2015
- Published by Medknow
- Vol. 44 (4) , 265-70
Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis
Objective: In Sweden, reports indicate surprisingly large regional variation in prescription of biological drugs, despite a growing number of clinical studies describing their beneficial effects and guidelines by professional organizations and agencies. Our objective was to ascertain whether there is also variation between individual rheumatologists in prescribing biologics to patients with rheumatoid arthritis (RA) and to evaluate reasons for treatment choices. Methods: Ten hypothetical patient cases were constructed and presented to 26 rheumatologists in five regions in Sweden. The cases were based on actual cases and were thoroughly elaborated by a senior rheumatologist and pre-tested in a pilot study. The respondents were asked whether they would treat the patients with a biological agent (YES/NO) and to explain their decisions. Results: The response rate was 26/105; 25%. Treatment choices varied considerably between the rheumatologists, some prescribing biologics to 9/10 patients and others to 2/10. In five of the ten hypothetical cases, approximately half of the respondents would prescribe biologics. No regions with particularly high or low prescription were identified. Both the decision to prescribe biologics, as well as not to prescribe, were mainly motivated by medical reasons. Some rheumatologists also referred to lifestyle-related factors or social function of the patient. Conclusion: The choice of initiation of biologics varied substantially among rheumatologists presented with hypothetical patient cases, and there were also disparities between rheumatologists practising at the same clinic. Treatment choices were primarily motivated by medical reasons. This situation raises concerns about a lack of consensus in RA treatment strategies
- Open Access
- 11 October 2014
- Published by Springer Nature in Implementation Science
- Vol. 9 (1) , 153
Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study
The introduction of biological drugs involved a fundamental change in the treatment of rheumatoid arthritis (RA). The extent to which biological drugs are prescribed to RA patients in different regions in Sweden varies greatly. Previous research has indicated that differences in health care practice at the regional level might obscure differences at the individual level. The objective of this study is to explore what influences individual rheumatologists’ decisions when prescribing biological drugs. Semi-structured interviews, utilizing closed- and open-ended questions, were conducted with senior rheumatologists, selected through a mix of random and purposive sampling. The interview questions consisted of two parts, with a “parallel mixed method” approach. In the first and main part, open-ended exploratory questions were posed about factors influencing prescription. In the second part, the rheumatologists were asked to rate predefined factors that might influence their prescription decisions. The Consolidated Framework for Implementation Research (CFIR) was used as a conceptual framework for data collection and analysis. Twenty-six rheumatologists were interviewed. A constellation of various factors and their interaction influenced rheumatologists’ prescribing decisions, including the individual rheumatologist's experiences and perceptions of the evidence, the structure of the department including responsibility for costs, peer pressure, political and administrative influences, and participation in clinical trials. The patient as an actor emerged as an important factor. Hence, factors both at organizational and individual levels influenced the prescribing of biological drugs. The factors should not be seen as individual influences but were described as influencing prescription in an interactive, nonlinear way. Potential factors explaining differences in prescription practice are experience and perception of the evidence on the individual level and the structure of the department and participation in clinical trials on the organizational level. The influence of patient attitudes and preferences and interpretation of scientific evidence seemed to be somewhat contradictory in the qualitative responses as compared to the quantitative rating, and this needs further exploration. An implication of the present study is that in addition to scientific knowledge, attempts to influence prescription behavior need to be multifactorial and account for interactions of factors between different actors.
- 11 October 2014
- Published by Springer Nature in Implementation Science
- Vol. 9 (1) , 153
Open AccessFactors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study
The introduction of biological drugs involved a fundamental change in the treatment of rheumatoid arthritis (RA). The extent to which biological drugs are prescribed to RA patients in different regions in Sweden varies greatly. Previous research has indicated that differences in health care practice at the regional level might obscure differences at the individual level. The objective of this study is to explore what influences individual rheumatologists’ decisions when prescribing biological drugs. Semi-structured interviews, utilizing closed- and open-ended questions, were conducted with senior rheumatologists, selected through a mix of random and purposive sampling. The interview questions consisted of two parts, with a “parallel mixed method” approach. In the first and main part, open-ended exploratory questions were posed about factors influencing prescription. In the second part, the rheumatologists were asked to rate predefined factors that might influence their prescription decisions. The Consolidated Framework for Implementation Research (CFIR) was used as a conceptual framework for data collection and analysis. Twenty-six rheumatologists were interviewed. A constellation of various factors and their interaction influenced rheumatologists’ prescribing decisions, including the individual rheumatologist's experiences and perceptions of the evidence, the structure of the department including responsibility for costs, peer pressure, political and administrative influences, and participation in clinical trials. The patient as an actor emerged as an important factor. Hence, factors both at organizational and individual levels influenced the prescribing of biological drugs. The factors should not be seen as individual influences but were described as influencing prescription in an interactive, nonlinear way. Potential factors explaining differences in prescription practice are experience and perception of the evidence on the individual level and the structure of the department and participation in clinical trials on the organizational level. The influence of patient attitudes and preferences and interpretation of scientific evidence seemed to be somewhat contradictory in the qualitative responses as compared to the quantitative rating, and this needs further exploration. An implication of the present study is that in addition to scientific knowledge, attempts to influence prescription behavior need to be multifactorial and account for interactions of factors between different actors.
- 1 September 2014
- Vol. 111 (37) , 1492-3
[Do something about the ethics of diagnostics!].
- Open Access
- 13 August 2014
- Published by Springer Nature in BMC Nursing
- Vol. 13 (1) , 23
Facilitators and barriers influencing patient safety in Swedish hospitals: a qualitative study of nurses’ perceptions
Sweden has undertaken many national, regional, and local initiatives to improve patient safety since the mid-2000s, but solid evidence of effectiveness for many solutions is often lacking. Nurses play a vital role in patient safety, constituting 71% of the workforce in Swedish health care. This interview study aimed to explore perceived facilitators and barriers influencing patient safety among nurses involved in the direct provision of care. Considering the importance of nurses with regard to patient safety, this knowledge could facilitate the development and implementation of better solutions.
- 13 August 2014
- Published by Springer Nature in BMC Nursing
- Vol. 13 (1) , 23
Open AccessFacilitators and barriers influencing patient safety in Swedish hospitals: a qualitative study of nurses’ perceptions
Sweden has undertaken many national, regional, and local initiatives to improve patient safety since the mid-2000s, but solid evidence of effectiveness for many solutions is often lacking. Nurses play a vital role in patient safety, constituting 71% of the workforce in Swedish health care. This interview study aimed to explore perceived facilitators and barriers influencing patient safety among nurses involved in the direct provision of care. Considering the importance of nurses with regard to patient safety, this knowledge could facilitate the development and implementation of better solutions.
- Top Cited PapersOpen Access
- 10 June 2013
- Published by Springer Nature in Implementation Science
- Vol. 8 (1) , 63
Never the twain shall meet? - a comparison of implementation science and policy implementation research
Many of society’s health problems require research-based knowledge acted on by healthcare practitioners together with implementation of political measures from governmental agencies. However, there has been limited knowledge exchange between implementation science and policy implementation research, which has been conducted since the early 1970s. Based on a narrative review of selective literature on implementation science and policy implementation research, the aim of this paper is to describe the characteristics of policy implementation research, analyze key similarities and differences between this field and implementation science, and discuss how knowledge assembled in policy implementation research could inform implementation science.
- 10 June 2013
- Published by Springer Nature in Implementation Science
- Vol. 8 (1) , 63
Top Cited PapersOpen AccessNever the twain shall meet? - a comparison of implementation science and policy implementation research
Many of society’s health problems require research-based knowledge acted on by healthcare practitioners together with implementation of political measures from governmental agencies. However, there has been limited knowledge exchange between implementation science and policy implementation research, which has been conducted since the early 1970s. Based on a narrative review of selective literature on implementation science and policy implementation research, the aim of this paper is to describe the characteristics of policy implementation research, analyze key similarities and differences between this field and implementation science, and discuss how knowledge assembled in policy implementation research could inform implementation science.
- Open Access
- 8 February 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 52
Factors influencing patient safety in Sweden: perceptions of patient safety officers in the county councils
National, regional and local activities to improve patient safety in Sweden have increased over the last decade. There are high ambitions for improved patient safety in Sweden. This study surveyed health care professionals who held key positions in their county council’s patient safety work to investigate their perceptions of the conditions for this work, factors they believe have been most important in reaching the current level of patient safety and factors they believe would be most important for achieving improved patient safety in the future.
- 8 February 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 52
Open AccessFactors influencing patient safety in Sweden: perceptions of patient safety officers in the county councils
National, regional and local activities to improve patient safety in Sweden have increased over the last decade. There are high ambitions for improved patient safety in Sweden. This study surveyed health care professionals who held key positions in their county council’s patient safety work to investigate their perceptions of the conditions for this work, factors they believe have been most important in reaching the current level of patient safety and factors they believe would be most important for achieving improved patient safety in the future.